Identifying and sharing good practices:
The Network has identified four priority areas of drug dependence treatment and rehabilitation. By sharing of good practices the aim is to assist service providers to improve the quality of the services and to guide policy-makers in programming and planning. Special attention will be given to the needs of women and young people.
The four priority areas are as follows:
- Integrate drug treatment and rehabilitation programmes into community health and social services
- Community participation
- Sustainability and accountability to the community
Drug treatment and rehabilitation in prison settings
- Treatment services available in prisons are equivalent to those in the community - Principle of equivalence
- Impact on crime rate and recidivism
- Linking prisoners to community services after release
Role of drug dependence treatment on HIV/AIDS prevention and care
- Access to a range of evidence-based treatments including methadone and buprenorphine
- Availability of information on HIV prevention, Voluntary Confidential Counselling and Testing (VCCT) and anti retroviral therapy (ARV)
- Outreach services and working with vulnerable groups
Sustainable livelihoods, rehabilitation and reintegration
- Vocational training, occupational and educational opportunities
- Building community - family support and engagement
- Accessing opportunities for housing
The capacity-building component will be implemented by a consortium of 10 leading institutions on drug dependence treatment training and service provision, led by the University of California, Los Angeles/Integrated Substance Abuse Programme (UCLA/ISAP). The Network’s capacity-building plan, includes the compilation of a training package applicable to different socioeconomic settings. In addition, it addresses capacity-building of drug dependency treatment professionals at the resource centres through training of trainers and on-site training. These individuals can in turn become trainers and create a multiplier effect in their respective regions.
Treatnet wishes to thank the following donors for their generous contributions to this effort: Canada, Germany, Netherlands, Spain, Sweden, U.S.A., and the Robert Wood Johnson Foundation.
- Turning Point Alcohol and Drug Centre Inc., Australia
- Psychosocial Attention Centre for Alcohol and other Drugs, Brazil
- Centre for Addiction and Mental Health CAMH, Canada
- Shanghai Drug Abuse Treatment Centre, China
- Carisma Centre for Attention and Integral Mental Health, Colombia
- General Secretariat of Mental Health, Egypt
- Mudra, Germany
- TT Ranganathan Clinical Research Foundation, India
- RS Ketergantungan Obat The Drug Dependence Hospital, Indonesia
- Iranian National Prison Organisation /Iranian National Centre for Addiction Studies INCAS, Iran
- National Research and Clinical Centre on Medical and Social Problems of Drug, Kazakhstan
- Drug Rehabilitation Unit, Mathari Hospital, Kenya
- Centros de Integración Juvenil A.C., Mexico
- Neuropsychiatric Hospital Aro, Nigeria
- Regional Research Centre of Narcology and Psychopharmacology
St. Petersburg Pavlov State Medical University, Russia
- Asociación Proyecto Hombre, Spain
- Maria Ungdom, Sweden
- Cranstoun Drug Services, United Kingdom
- Fayette Companies, U.S.A.
- Stanley Street Treatment & Resources (SSTAR) Inc., U.S.A.